Ibritumomab Tiuxetan and Pedia-Lax Chewable
Determining the interaction of Ibritumomab Tiuxetan and Pedia-Lax Chewable and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: magnesium hydroxide
Brand name: Ex-Lax Milk of Magnesia, Milk of Magnesia, Pedia-Lax Chewable, Phillips Milk of Magnesia, Dulcolax Milk of Magnesia, Concentrated Phillips Milk of Magnesia
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Pedia-Lax Liquid rectal
- Ibritumomab Tiuxetan-Pediacare
- Ibritumomab Tiuxetan-PediaCare Children’s Multi-Symptom
- Ibritumomab Tiuxetan-PediaCare Cold/Allergy
- Ibritumomab Tiuxetan-Pediacare Decongestant Infants
- Ibritumomab Tiuxetan-Pediacare Long-Acting Cough
- Pedia-Lax Chewable-Ibrutinib
- Pedia-Lax Chewable-Ibrutinib Capsules
- Pedia-Lax Chewable-Ibrutinib Tablets
- Pedia-Lax Chewable-Ibu
- Pedia-Lax Chewable-IBU Tablets
- Pedia-Lax Chewable-Ibu-2